产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
依法韦仑是一种非核苷类逆转录酶抑制剂(NNRTI)。它是一种抗HIV药物，常用于AIDs治疗的联合疗法。它是用于治疗人类免疫缺陷病毒(HIV)1型的高效抗逆转录病毒疗法(HAART)的一部分。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAB8364 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C14H9ClF3NO2 |
| 分子量 | 315.67 |
| MDL编号 | MFCD05662344 |
| NACRES | NA.24 |
产品性质
| 质量水平 | 300 |
| 等级 | certified reference material pharmaceutical secondary standard |
| 形式 | powder |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 500 mg |
| 药典可追溯性 | traceable to USP 1234103 |
| 储存温度 | 2-30℃ |
| SMILES string | ClC1=CC=C2C([C@@](C#CC3CC3)(C(F)(F)F)OC(N2)=O)=C1 |
| InChI | 1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1 |
| InChI key | XPOQHMRABVBWPR-ZDUSSCGKSA-N |
安全信息
| 象形图 |    |
| 警示用语： | Danger |
| 危险声明 | H302 - H360 - H410 |
| 预防措施声明 | P202 - P264 - P270 - P273 - P301 + P312 - P308 + P313 |
| 危险分类 | Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B |
| 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
